Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Astepro is a nasal spray with antihistamine, which Rubin usually recommends pairing with a steroid spray. Steroid nasal ...

Skills vary significantly among endoscopists, and a high miss rate is reported. Automated polyp segmentation can reduce the missed rates, and timely treatment is possible in the early stage. To ...

Indication Systemic corticosteroids have been demonstrated ... [102] However, antihistamines are recommended for those patients with nasal polyps associated with atopy. Controversies See the ...

Corticosteroids: Oral or nasal corticosteroids are commonly used to treat nasal polyps. These can shrink the growths and provide partial relief for some people. For long-term relief, though, surgery ...

State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of ...

Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

The patients required IL-5 inhibitors (mepolizumab or benralizumab) because of contraindications to or failure of oral, intravenous, or ocular steroid treatment or various immunomodulators.

inhaled corticosteroids, nasal corticosteroids, and ophthalmic corticosteroids, each tailored for specific medical needs and modes of delivery. In terms of application, corticosteroids are widely ...

This is the case for most sinus infections. Symptoms of viral sinus infections may be treated with the following: Nasal polyps may be treated with intranasal or oral corticosteroids to shrink their ...

the need of systemic steroid use remains high, which is associated with adverse effects such as infections, diabetes, obesity, osteoporosis, cardiovascular disease, and cataracts. Furthermore, 40% of ...

1. In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...